Company: IPSC
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001558370-25-011575
Chunk: 2

Company: Century Therapeutics, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1F
Chunk 2
---
Item 1. Unaudited Consolidated Financial Statements.

CENTURY THERAPEUTICS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

​

​​​​​​​​​​June 30, 2025​December 31, 2024​​    (unaudited)    ​​Assets​​​​​​​​​​​​​​​Current assets​​​​​​​Cash and cash equivalents​$56,878​$ 58,441​Short-term investments​ 98,965​  130,851​Prepaid expenses and other current assets​ 4,326​  4,759​Total current assets​  160,169​  194,051​​​​​​​​​Property and equipment, net​ 56,649​  62,141​Operating lease right-of-use assets​​27,737​​ 28,706​Restricted cash​​2,709​​ 2,772​Long-term investments​ 2,690​  30,818​Intangible assets​​ 34,200​​ 34,200​Security deposits and non-current assets​  538​  528​Total assets​$ 284,692​$ 353,216​​​​​​​​​Liabilities and stockholders’ equity​   ​   ​​​​​​​​​Current liabilities​ ​​   ​Accounts payable​$ 3,208​$ 3,075​Accrued expenses and other liabilities​  11,720​  17,461​Deposit liability ​​ 20​​ 82​Deferred revenue, current​​ —​​ 109,164​Total current liabilities​  14,948​  129,782​​​​​​​​​Operating lease liability, long term​  46,589​  48,960​Contingent consideration liability​  8,883​  8,738​Deferred tax liability​  4,374​  4,374​​​​​​​​​Total liabilities​  74,794​  191,854​​​​​​​​​Commitments and contingencies (Note 8)​   ​   ​Stockholders' equity:​​​​​​​Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively​​ —